XOMAP
XOMA Corporation
NASDAQ · Healthcare · Biotechnology · US
$24.98
+0.00%Margins
Gross margin
94.3%
EBITDA margin
184.3%
EBIT margin
18.1%
Net margin
123.3%
FCF margin
24.2%
29.9%
Return on equity
12.4%
Return on assets
2.1%
Return on invested capital
0.10x
Asset turnover
$6.6M
Cash from operations
$97
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026